ArticleBlood advances2022

Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT.

Mouhamed Yazan Abou-Ismail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.